Filing Flows › Syra Health (SYRA) › Guidance & outlook
Syra Health (SYRA) guidance and outlook
Syra Health's 10-Q filed Nov 3, 2026 makes 17 forward-looking statements.
Guidance and outlook
Forward-looking statements, 10-Q filed Nov 3, 2026
- Within our digital health service line, we intend to offer SyraBot a chatbot designed to foster connectivity and engagement throughout individuals’ care journeys, offering members round-the-clock access to necessary information via our AI-powered customer support chat system), CarePlus (an electronic medical records solution designed for small to mid-sized healthcare organization) and patient engagement and…
- We believe that our solutions will assist individuals in reaching their full health potential through preventative care, care coordination and patient engagement.
- We believe that targeted and continuous healthcare education solutions are needed to help healthcare professionals improve their competency, improve health equality and incorporate innovative and new therapeutic options into practice to improve overall patient care quality.
- Therefore, we aim to provide medical education solutions to pharmaceutical and medical device manufacturers, biotechnology companies, payers, large employers, academic institutions, and government agencies.
- Some of our targeted education approaches include the utilization of artificial intelligence tools to provide real-time information to customers.
- As we continue our expansion, we anticipate that our professional pool and infrastructure will grow to support the breadth and depth of our services.
- With our rapid growth of sales and business development teams, we intend to replicate our current projects with similar customers across the country.
- We plan to open offices in multiple geographical locations to support our sales and business development efforts and intend to invest in partnerships with subject matter experts to further enhance our service lines and provide real-world insights.
- It is anticipated that such companies will strengthen our current service offerings and may also include new services that we may offer to our clients.
- Additionally, our government solutions service line of business positions us to work on federal government healthcare and related projects from several agencies such as the United States Department of Health and Human Services, the Centers for Disease Control and Prevention, the National Institutes of Health, the National Aeronautics and Space Administration and the United States Department of Defence.
- These factors, and the possibility of further spending reviews and cancellations are expected to negatively affect the quantity and time of our revenue, results of operations and cash flows in the near term.
- Our cost of services increased primarily due to an increase in labor costs associated with the increased volume of contracts, and increased consulting costs associated with a slight change in service mix from healthcare workforce services to project-based population health services that carry better margins.
Syra Health's latest quarter
Syra Health, Q3 2026: revenue $2.6M (+52% year over year), operating margin 11.7%, net earnings $345K, operating cash flow $332K. The chart follows the revenue to costs, profit and cash.
Questions
What does Syra Health expect?
Within our digital health service line, we intend to offer SyraBot a chatbot designed to foster connectivity and engagement throughout individuals’ care journeys, offering members round-the-clock access to necessary information via our AI-powered customer support chat system), CarePlus (an electronic medical records solution designed for small to mid-sized healthcare organization) and patient engagement and… We believe that our solutions will assist individuals in reaching their full health potential through preventative care, care coordination and patient engagement. We believe that targeted
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.